Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
| Brand name | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE |
| Generic name | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE |
| Active ingredient(s) | ALBUTEROL SULFATE, IPRATROPIUM BROMIDE |
| Distributed by / for | Cipla USA Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059 |
| NDC | 69097-840-64 |
| Full product label | Ipratropium Bromide and Albuterol Sulfate Inhalation Solution (0.5 mg/3 mg per 3 mL), 60 x 3 mL Sterile Unit-Dose Vials (2 pouches of 30 - 3 mL vials each), Manufactured By: The Ritedose Corporation, Columbia, SC 29203; Distributed By: Cipla USA Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-840-64 |
| Recalling firm | CARDINAL HEALTHCARE |
| Distribution | Nationwide USA |
| Quantity | 2 cartons |
| Recall initiated | 2022-01-26 |
| Report date | 2024-01-03 |
| Recall completed | 2024-09-29 |
| Recall number | D-0161-2024 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Dublin OH United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗